AHA Presents Up-To-Date Statistics for Cardiovascular Disease
19.05 million deaths estimated for CVD globally in 2020, representing an increase of 18.71 percent from 2010
19.05 million deaths estimated for CVD globally in 2020, representing an increase of 18.71 percent from 2010
Patients with advanced CKD have not been well-represented in trials evaluating intensive blood pressure control.
The systematic review and meta-analysis included a broad range of patients with and without chronic kidney disease.
Occurrence of major cardiovascular events, non-cancer-related deaths no lower with chlorthalidone versus hydrochlorothiazide
No association seen for people with optimal and normal BP, high-normal BP, grade 1 hypertension
Quinapril Tablet is indicated for the treatment of hypertension.
Blocking the endothelin pathway could represent a new mode of action to lower blood pressure in resistant hypertension, according to investigators.
The table provided is a review of notable updates that occurred in November 2022 for investigational products in development.
Improvements seen in blood pressure and central and peripheral aortic stiffness and pressure hemodynamics in teens with type 1 diabetes
Stopping renin-angiotensin-aldosterone inhibitors after hyperkalemia may offset their potential clinical benefits, according to investigators.